2018 financial statements
A conference call will be held today, March 20, 2019, at 2:00pm (CEST) Management Participants: Mondher Mahjoubi, CEO, Laure-Helene Mercier, CFO, Pierre Dodion, CMO, and Jennifer Butler, US General Manager
Welcome to Innate Pharma
Scroll
About Innate Pharma
Innate Pharma S.A. is a fully integrated oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
Headlines
ASH 2018: updated results on IPH4102 and KOL webcast
A KOL webcast and conference call was held on Tuesday, December 4, at 5pm CET (8am PST)
Innate Pharma strengthens and expands its oncology development collaboration with AstraZeneca
Conference call for analysts and investors to discuss this announcement.
Latest news
Upcoming events
15th European Association of Dermato-Oncology Congress | Paris, France
April 24, 2019 to April 27, 2019
5th International Conference of translational medicine on pathogenesis and therapy of immunomediated diseases | Milan, Italy
May 16, 2019 to May 18, 2019
ASCO Annual Meeting | Chicago, USA
May 31, 2019 to June 4, 2019